Yu Zhiyi, van Veldhoven Jacobus P D, 't Hart Ingrid M E, Kopf Adrian H, Heitman Laura H, IJzerman Adriaan P
Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, 2300 RA Leiden, The Netherlands.
Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, 2300 RA Leiden, The Netherlands.
Eur J Med Chem. 2015 Dec 1;106:50-9. doi: 10.1016/j.ejmech.2015.10.032. Epub 2015 Oct 21.
We synthesized and evaluated a series of compounds for their allosteric modulation at the Kv11.1 (hERG) channel. Most compounds were negative allosteric modulators of [(3)H]dofetilide binding to the channel, in particular 7f, 7h-j and 7p. Compounds 7f and 7p were the most potent negative allosteric modulators amongst all ligands, significantly increasing the dissociation rate of dofetilide in the radioligand kinetic binding assay, while remarkably reducing the affinities of dofetilide and astemizole in a competitive displacement assay. Additionally, both 7f and 7p displayed peculiar displacement characteristics with Hill coefficients significantly distinct from unity as shown by e.g., dofetilide, further indicative of their allosteric effects on dofetilide binding. Our findings in this investigation yielded several promising negative allosteric modulators for future functional and clinical research with respect to their antiarrhythmic propensities, either alone or in combination with known Kv11.1 blockers.
我们合成并评估了一系列化合物对Kv11.1(hERG)通道的变构调节作用。大多数化合物是[³H]多非利特与该通道结合的负性变构调节剂,尤其是7f、7h - j和7p。化合物7f和7p是所有配体中最有效的负性变构调节剂,在放射性配体动力学结合试验中显著增加多非利特的解离速率,而在竞争性置换试验中显著降低多非利特和阿司咪唑的亲和力。此外,7f和7p均表现出特殊的置换特征,其希尔系数明显不同于例如多非利特的单位值,进一步表明它们对多非利特结合的变构效应。我们在这项研究中的发现产生了几种有前景的负性变构调节剂,可用于未来关于其抗心律失常倾向的功能和临床研究,无论是单独使用还是与已知的Kv11.1阻滞剂联合使用。